Larimar Therapeutics, Inc. Annual Operating Income (Loss) in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Larimar Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2012 to 2023.
  • Larimar Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$18.3M, a 76.7% decline year-over-year.
  • Larimar Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$73.8M, a 93.9% decline year-over-year.
  • Larimar Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$41.8M, a 14.3% decline from 2022.
  • Larimar Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$36.5M, a 27.6% increase from 2021.
  • Larimar Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$50.5M, a 17.9% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$41.8M -$5.23M -14.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-14
2022 -$36.5M +$13.9M +27.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 -$50.5M -$7.66M -17.9% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-14
2020 -$42.8M -$19.6M -84.4% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-25
2019 -$23.2M +$37.9M +62% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-04
2018 -$61.1M -$8.12M -15.3% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-05
2017 -$53M +$5.23M +8.98% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-05
2016 -$58.2M +$15.6M +21.1% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-14
2015 -$73.8M -$38.3M -108% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-09
2014 -$35.5M -$21.8M -158% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-10
2013 -$13.8M +$11K +0.08% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-15
2012 -$13.8M Jan 1, 2012 Dec 31, 2012 10-K 2015-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.